HC Wainwright & Co. Maintains Buy on Asensus Surgical, Maintains $2 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains a Buy rating on Asensus Surgical (AMEX:ASXC) with a maintained price target of $2.
March 22, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Asensus Surgical maintained at Buy by HC Wainwright & Co. with a $2 price target.
The reaffirmation of a Buy rating and a $2 price target by a reputable analyst firm like HC Wainwright & Co. is likely to instill confidence among investors and could positively influence Asensus Surgical's stock price in the short term. The specific mention of the company and the maintenance of the price target suggest a strong belief in the company's potential.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100